Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 ReleaseZacks Investment Research • 03/02/26
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell TumorsGlobeNewsWire • 12/09/25
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing LossGlobeNewsWire • 12/02/25
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/26/25
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/13/25
Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/30/25
Adherex Technologies Inc. (FENC) Reports Q2 Loss, Beats Revenue EstimatesZacks Investment Research • 08/14/25
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business UpdateGlobeNewsWire • 08/14/25
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025GlobeNewsWire • 08/11/25
Recent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's WhyZacks Investment Research • 07/15/25
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/13/25
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025GlobeNewsWire • 05/08/25
Wall Street Analysts See an 113.25% Upside in Adherex Technologies (FENC): Can the Stock Really Move This High?Zacks Investment Research • 04/30/25
Down -22.15% in 4 Weeks, Here's Why Adherex Technologies (FENC) Looks Ripe for a TurnaroundZacks Investment Research • 04/10/25
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 03/10/25